AR-C126313 free base
AR-C118925XX is a selective P2Y2 receptor antagonist.
For research use only. Not for human or veterinary use.
Target
P2Y Receptor
Purity >98%
Stock Inquire
AR-C126313 structure
CAS No.: 216657-60-2
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 5 mg | USD 410.00 | BP-02440-5mg | In stock | Get quote |
| 10 mg | USD 660.00 | BP-02440-10mg | In stock | Get quote |
| 25 mg | USD 1,310.00 | BP-02440-25mg | In stock | Get quote |
| 50 mg | USD 2,100.00 | BP-02440-50mg | In stock | Get quote |
| 100 mg | USD 3,360.00 | BP-02440-100mg | In stock | Get quote |
| 250 mg | Inquire | BP-02440-250mg | In stock | Inquire |
Need another size or custom synthesis? Request a quote.
Description
AR-C118925XX is a selective P2Y2 receptor antagonist. AR-C118925XX inhibits ATP-induced IL-6 production and phosphorylation of p38. AR-C118925XX also inhibits Bleomycin -induced dermal fibrosis in mice. AR-C118925XX also inhibits ATP-induced tumor growth .
Biological activity
In Vivo AR-C118925XX (i.p.) suppresses Bleomycin-enhanced dermal thickness in mice.
Identifiers
- SMILES
-
O=C(C1=CC=C(CN2C=C(C3C4=CC=C(C)C=C4C=CC5=CC(C)=CC=C53)C(NC2=O)=S)O1)NC6=NN=NN6 - InChIKey
-
PVKNPGQAFNALOI-UHFFFAOYSA-N
Specifications
- MW (average)
- 537.5920
- Formula
- C28H23N7O3S
- CAS No.
- 216657-60-2
- Physical state
- Solid
- Color
- Light yellow to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- -20°C, sealed storage, away from moisture
Solubility
Soluble in DMSO : 100 mg/mL
Documents
References
[1].Perera LMB, et al. The Regulation of Skin Fibrosis in Systemic Sclerosis by Extracellular ATP via P2Y2 Purinergic Receptor. J Invest Dermatol. 2019 Apr;139(4):890-899.
[2].Dong CR, et al. AKT/GSK-3beta/VEGF signaling is involved in P2RY2 activation-induced the proliferation and metastasis of gastric cancer. Carcinogenesis. 2022 Dec 5:bgac095.
Same research area
Search Inflammation/Immunology- BP-00001 KN-92 free base · >98%
- BP-00084 ORIC-944 free base · >98%
- BP-00101 Oditrasertib free base · >98%
- BP-00104 BMS-986397 free base · >98%
- BP-00343 Opadotin free base · >98%
- BP-00353 MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan free base · >98%
- BP-00726 Ortho-AP1867 free base · >98%
- BP-00752 CR-1-31-B free base · >98%